Skip to main content
A research group out of Washington state presented their findings on cannabis use among dermatology patients at the AAD VMX 2020.
Findings from a recent poster abstract highlighted the the amount of supplements patients with alopecia would take in a day compared with the general population.

As an oral selective inhibitor of Januse kinase (JAK) 1 and JAK 2, which may play a role in the inflammatory response of atopic dermati

Glabellar lines are one of the most commonly requested sites for neuromodulator injection, and clinical trials for a new type A botulin

Researchers have found that once-daily tazarotene 0.045% is efficacious with a favorable safety and tolerability profile for the treatm

Data on the efficacy and safety of bimekizumab from 2 phase 3 clinical trials presented at the American Academy of Dermatology Virtual Meeting Experience 2020 showed promising results for the treatment of moderate to severe plaque psoriasis.
To meet the educational needs and plenary requirements normally fulfilled by its in-person event, the Academy announced the AAD Virtual Meeting Experience (VMX), set to take place June 12 to June 14, 2020.
Back to Top